ZenaTech's Q3 2026 report serves as an important checkpoint for its acquisition-driven Drone as a Service strategy. In the first half of 2026, the company recorded revenue of roughly C$17.7 million (about US$12.6 million), up 425% year over year and already exceeding the C$12.9 million full-year total from 2025. DaaS operations represented 93% of that half-year figure. Given the business remains unprofitable amid rapid scaling, this report provides a useful gauge of how growth and spending are balancing. I am watching closely to see whether the strong preliminary revenue guidance leads to narrower losses and further progress toward the 2027 adjusted EBITDA breakeven target.
Analyst consensus for the quarter points to a loss of about $0.18 per share on revenue near $9.12 million. That revenue estimate would mark a substantial increase from the roughly $3.1 million recorded in the year-ago period. Management has already issued preliminary, unaudited guidance for Q3 2026 revenue of C$13.4 million to C$14.8 million, or approximately US$9.5 million to US$10.5 million, implying 44% to 59% sequential growth from the second quarter's US$6.57 million.
For comparison, ZenaTech reported a net loss of $0.20 per share on revenue of $6.57 million in Q2 2026. The company has not consistently beaten EPS expectations in recent quarters, so attention will likely center on revenue execution, DaaS momentum, and any updates on the 2027 breakeven timeline. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Sentiment heading into this report reflects the balance between rapid revenue growth and ongoing losses. ZenaTech's stock has shown notable volatility, and the company has relied on share sales and an expanded at-the-market facility to support its acquisition strategy, which raises dilution considerations. The preliminary Q3 revenue range, which exceeds consensus, has provided bulls with a clear catalyst, while bears continue to focus on cash burn, integration risks across acquired DaaS locations, and the path to profitability. As a result, the market reaction may depend less on the headline loss and more on whether actual revenue reaches the upper end of guidance and whether management reaffirms its 2027 adjusted EBITDA breakeven target.
Looking beyond the Q3 2026 print, several elements will shape the narrative for ZenaTech. Investors should watch whether reported revenue falls within or above the $9.5 million to $10.5 million preliminary range and how it compares with the $9.12 million consensus. A result near the top of guidance would support the DaaS growth story, while a shortfall could prompt questions about integration.
Margin and cost trends are equally important. Management is targeting adjusted EBITDA breakeven in 2027 but has also indicated it may continue spending on acquisitions, defense technology, and international expansion even if that extends the timeline. Commentary on cash reserves, dilution from the expanded ATM facility, and operating efficiency will draw scrutiny.
Broader industry dynamics also matter. Demand tied to AI data center construction, residential surveying, and government and defense drone programs could affect future quarters. Monitoring the pace of new DaaS acquisitions, organic growth at existing sites, and updates on defense certifications or international expansion will be key after the release.
In my regular analysis of growth-oriented names like ZenaTech, I find Tickeron's AI Screener particularly useful for quickly scanning technical patterns, fundamentals, and industry trends. It allows me to filter thousands of stocks efficiently and surface relevant ideas without manual effort, helping refine my focus on sectors such as drones and technology before diving deeper into individual reports.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ZENA declined for three days, in 144 of 158 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ZENA entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Moving Average Convergence Divergence (MACD) for ZENA just turned positive on November 16, 2026. Looking at past instances where ZENA's MACD turned positive, the stock continued to rise in 12 of 14 cases over the following month. The odds of a continued upward trend are 86%.
Following a +9.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZENA advanced for three days, in 69 of 82 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
ZENA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.558) is normal, around the industry mean (16.188). P/E Ratio (-0.383) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (4.342) is also within normal values, averaging (103.301).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. ZENA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZENA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications